vs
Information Services Group Inc.（III）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Information Services Group Inc.的1.1倍（$69.8M vs $61.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 4.3%，领先379.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 5.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -2.4%）
EBSCO信息服务总部位于马萨诸塞州伊普斯威奇，隶属于总部设在阿拉巴马州伯明翰的私营企业EBSCO工业集团。该企业面向全球各类图书馆提供信息产品与服务，核心产品包含全流程电子资源管理系统EBSCONET，以及付费在线研究服务平台EBSCOhost，平台拥有375个全文数据库与超60万册电子书资源。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
III vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$61.2M
营收增速更快
RIGL
高出15.2%
5.9%
净利率更高
RIGL
高出379.8%
4.3%
两年增速更快
RIGL
近两年复合增速
-2.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.2M | $69.8M |
| 净利润 | $2.6M | $268.1M |
| 毛利率 | 44.8% | 91.5% |
| 营业利润率 | 8.4% | 33.2% |
| 净利率 | 4.3% | 384.0% |
| 营收同比 | 5.9% | 21.2% |
| 净利润同比 | -14.1% | 1769.2% |
| 每股收益（稀释后） | $0.06 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIIRIGL
| Q4 25 | $61.2M | $69.8M | ||
| Q3 25 | $62.4M | $69.5M | ||
| Q2 25 | $61.6M | $101.7M | ||
| Q1 25 | $59.6M | $53.3M | ||
| Q4 24 | $57.8M | $57.6M | ||
| Q3 24 | $61.3M | $55.3M | ||
| Q2 24 | $64.3M | $36.8M | ||
| Q1 24 | $64.3M | $29.5M |
净利润IIIRIGL
| Q4 25 | $2.6M | $268.1M | ||
| Q3 25 | $3.1M | $27.9M | ||
| Q2 25 | $2.2M | $59.6M | ||
| Q1 25 | $1.5M | $11.4M | ||
| Q4 24 | $3.0M | $14.3M | ||
| Q3 24 | $1.1M | $12.4M | ||
| Q2 24 | $2.0M | $-1.0M | ||
| Q1 24 | $-3.4M | $-8.2M |
毛利率IIIRIGL
| Q4 25 | 44.8% | 91.5% | ||
| Q3 25 | 42.2% | 93.2% | ||
| Q2 25 | 42.2% | 95.6% | ||
| Q1 25 | 43.1% | 91.7% | ||
| Q4 24 | 41.5% | 89.9% | ||
| Q3 24 | 40.4% | 85.5% | ||
| Q2 24 | 39.5% | 92.4% | ||
| Q1 24 | 36.1% | 93.1% |
营业利润率IIIRIGL
| Q4 25 | 8.4% | 33.2% | ||
| Q3 25 | 7.4% | 40.9% | ||
| Q2 25 | 7.6% | 60.1% | ||
| Q1 25 | 5.7% | 23.9% | ||
| Q4 24 | 0.3% | 28.9% | ||
| Q3 24 | 7.0% | 25.4% | ||
| Q2 24 | 5.7% | 1.2% | ||
| Q1 24 | -3.7% | -23.6% |
净利率IIIRIGL
| Q4 25 | 4.3% | 384.0% | ||
| Q3 25 | 4.9% | 40.2% | ||
| Q2 25 | 3.5% | 58.6% | ||
| Q1 25 | 2.5% | 21.5% | ||
| Q4 24 | 5.3% | 24.9% | ||
| Q3 24 | 1.9% | 22.5% | ||
| Q2 24 | 3.2% | -2.8% | ||
| Q1 24 | -5.3% | -27.9% |
每股收益（稀释后）IIIRIGL
| Q4 25 | $0.06 | $14.11 | ||
| Q3 25 | $0.06 | $1.46 | ||
| Q2 25 | $0.04 | $3.28 | ||
| Q1 25 | $0.03 | $0.63 | ||
| Q4 24 | $0.07 | $0.82 | ||
| Q3 24 | $0.02 | $0.70 | ||
| Q2 24 | $0.04 | $-0.06 | ||
| Q1 24 | $-0.07 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $94.7M | $391.5M |
| 总资产 | $211.0M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资IIIRIGL
| Q4 25 | $28.7M | $155.0M | ||
| Q3 25 | $28.7M | $137.1M | ||
| Q2 25 | $25.2M | $108.4M | ||
| Q1 25 | $20.1M | $77.1M | ||
| Q4 24 | $23.1M | $77.3M | ||
| Q3 24 | $9.7M | $61.1M | ||
| Q2 24 | $11.8M | $49.1M | ||
| Q1 24 | $14.0M | $49.5M |
总债务IIIRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益IIIRIGL
| Q4 25 | $94.7M | $391.5M | ||
| Q3 25 | $94.7M | $117.6M | ||
| Q2 25 | $94.1M | $81.9M | ||
| Q1 25 | $95.0M | $18.6M | ||
| Q4 24 | $96.3M | $3.3M | ||
| Q3 24 | $96.6M | $-14.6M | ||
| Q2 24 | $95.5M | $-29.9M | ||
| Q1 24 | $95.6M | $-31.7M |
总资产IIIRIGL
| Q4 25 | $211.0M | $513.6M | ||
| Q3 25 | $213.3M | $242.5M | ||
| Q2 25 | $200.7M | $206.7M | ||
| Q1 25 | $202.4M | $176.0M | ||
| Q4 24 | $204.5M | $164.0M | ||
| Q3 24 | $227.1M | $139.4M | ||
| Q2 24 | $235.3M | $128.4M | ||
| Q1 24 | $234.2M | $126.5M |
负债/权益比IIIRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $4.3M | — |
| 自由现金流率自由现金流/营收 | 7.0% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | 1.94× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $25.0M | — |
8季度趋势，按日历期对齐
经营现金流IIIRIGL
| Q4 25 | $5.1M | $22.0M | ||
| Q3 25 | $11.1M | $24.0M | ||
| Q2 25 | $11.9M | $30.5M | ||
| Q1 25 | $978.0K | $-893.0K | ||
| Q4 24 | $6.6M | $14.5M | ||
| Q3 24 | $8.8M | $21.7M | ||
| Q2 24 | $2.2M | $302.0K | ||
| Q1 24 | $2.3M | $-5.0M |
自由现金流IIIRIGL
| Q4 25 | $4.3M | — | ||
| Q3 25 | $9.5M | — | ||
| Q2 25 | $11.1M | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $6.0M | — | ||
| Q3 24 | $8.4M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $1.3M | — |
自由现金流率IIIRIGL
| Q4 25 | 7.0% | — | ||
| Q3 25 | 15.2% | — | ||
| Q2 25 | 18.0% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 2.0% | — |
资本支出强度IIIRIGL
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.6% | — |
现金转化率IIIRIGL
| Q4 25 | 1.94× | 0.08× | ||
| Q3 25 | 3.62× | 0.86× | ||
| Q2 25 | 5.46× | 0.51× | ||
| Q1 25 | 0.66× | -0.08× | ||
| Q4 24 | 2.15× | 1.01× | ||
| Q3 24 | 7.66× | 1.75× | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
